Details
| Stereochemistry | ACHIRAL |
| Molecular Formula | C16H16O3 |
| Molecular Weight | 256.2964 |
| Optical Activity | NONE |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 1 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
COC1=CC(\C=C\C2=CC=C(O)C=C2)=CC(OC)=C1
InChI
InChIKey=VLEUZFDZJKSGMX-ONEGZZNKSA-N
InChI=1S/C16H16O3/c1-18-15-9-13(10-16(11-15)19-2)4-3-12-5-7-14(17)8-6-12/h3-11,17H,1-2H3/b4-3+
| Molecular Formula | C16H16O3 |
| Molecular Weight | 256.2964 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 1 |
| Optical Activity | NONE |
Pterostilbene is a naturally derived compound found primarily in blueberries and Pterocarpus marsupium heartwood. The multiple benefits of pterostilbene in the treatment and prevention of human disease have been attributed to its antioxidant, anti-inflammatory, and anti-carcinogenic properties leading to improved function of normal cells and inhibition of malignant cells. The antioxidant activity of pterostilbene has been implicated in anti-carcinogenesis, modulation of neurological disease, anti-inflammation, attenuation of vascular disease, and amelioration of diabetes. Pterostilbene increases LDL and reduces blood pressure in adults. Low doses of pterostilbene seem to hold some benefit for cognition.
CNS Activity
Originator
Approval Year
Targets
| Primary Target | Pharmacology | Condition | Potency |
|---|---|---|---|
Target ID: CHEMBL2649 Sources: https://www.ncbi.nlm.nih.gov/pubmed/12033810 |
19.8 µM [IC50] | ||
Target ID: CHEMBL4321 Sources: https://www.ncbi.nlm.nih.gov/pubmed/12033810 |
83.9 µM [IC50] | ||
Target ID: WP408 |
|||
Target ID: WP400 Sources: https://www.ncbi.nlm.nih.gov/pubmed/19549798 |
Conditions
| Condition | Modality | Targets | Highest Phase | Product |
|---|---|---|---|---|
| Primary | Unknown Approved UseUnknown |
|||
| Preventing | Unknown Approved UseUnknown |
|||
| Primary | Unknown Approved UseUnknown |
PubMed
| Title | Date | PubMed |
|---|---|---|
| Pterostilbene Ameliorates Streptozotocin-Induced Diabetes through Enhancing Antioxidant Signaling Pathways Mediated by Nrf2. | 2016-01-19 |
|
| The berry constituents quercetin, kaempferol, and pterostilbene synergistically attenuate reactive oxygen species: involvement of the Nrf2-ARE signaling pathway. | 2014-10 |
|
| Pterostilbene, a dimethyl ether derivative of resveratrol, reduces fat accumulation in rats fed an obesogenic diet. | 2014-08-20 |
|
| Proteomic identification of pterostilbene-mediated anticancer activities in HepG2 cells. | 2014-07-21 |
|
| Synergistic induction of human cathelicidin antimicrobial peptide gene expression by vitamin D and stilbenoids. | 2014-03 |
|
| The stilbenes resveratrol, pterostilbene and piceid affect growth and stress resistance in mammalian cells via a mechanism requiring estrogen receptor beta and the induction of Mn-superoxide dismutase. | 2014-02 |
|
| A combination of pterostilbene with autophagy inhibitors exerts efficient apoptotic characteristics in both chemosensitive and chemoresistant lung cancer cells. | 2014-01 |
|
| Involvement of the Nrf2 pathway in the regulation of pterostilbene-induced apoptosis in HeLa cells via ER stress. | 2014 |
|
| In vitro and in vivo activities of pterostilbene against Candida albicans biofilms. | 2014 |
|
| Differences in the glucuronidation of resveratrol and pterostilbene: altered enzyme specificity and potential gender differences. | 2014 |
|
| 3,5,4'-Trimethoxystilbene, a natural methoxylated analog of resveratrol, inhibits breast cancer cell invasiveness by downregulation of PI3K/Akt and Wnt/β-catenin signaling cascades and reversal of epithelial-mesenchymal transition. | 2013-11-01 |
|
| The molecular basis for the inhibition of phosphodiesterase-4D by three natural resveratrol analogs. Isolation, molecular docking, molecular dynamics simulations, binding free energy, and bioassay. | 2013-10 |
|
| Stilbenes and anthocyanins reduce stress signaling in BV-2 mouse microglia. | 2013-06-26 |
|
| Pterostilbene induces mitochondrially derived apoptosis in breast cancer cells in vitro. | 2013-04 |
|
| Pterostilbene exerts antitumor activity against human osteosarcoma cells by inhibiting the JAK2/STAT3 signaling pathway. | 2013-02-08 |
|
| Pterostilbene, a natural analogue of resveratrol, potently inhibits 7,12-dimethylbenz[a]anthracene (DMBA)/12-O-tetradecanoylphorbol-13-acetate (TPA)-induced mouse skin carcinogenesis. | 2012-11 |
|
| Inhibition of nitric oxide and inflammatory cytokines in LPS-stimulated murine macrophages by resveratrol, a potent proteasome inhibitor. | 2012-07-10 |
|
| Genomic analysis of pterostilbene predicts its antiproliferative effects against pancreatic cancer in vitro and in vivo. | 2012-06 |
|
| 3,5-dibenzyloxy-4'-hydroxystilbene induces early caspase-9 activation during apoptosis in human K562 chronic myelogenous leukemia cells. | 2012-02 |
|
| Resveratrol increases the expression and activity of the low density lipoprotein receptor in hepatocytes by the proteolytic activation of the sterol regulatory element-binding proteins. | 2012-02 |
|
| Resveratrol modulates MED28 (Magicin/EG-1) expression and inhibits epidermal growth factor (EGF)-induced migration in MDA-MB-231 human breast cancer cells. | 2011-11-09 |
|
| Pterostilbene is more potent than resveratrol in preventing azoxymethane (AOM)-induced colon tumorigenesis via activation of the NF-E2-related factor 2 (Nrf2)-mediated antioxidant signaling pathway. | 2011-03-23 |
|
| Suppression of Heregulin-β1/HER2-Modulated Invasive and Aggressive Phenotype of Breast Carcinoma by Pterostilbene via Inhibition of Matrix Metalloproteinase-9, p38 Kinase Cascade and Akt Activation. | 2011 |
|
| Rational quantitative structure-activity relationship (RQSAR) screen for PXR and CAR isoform-specific nuclear receptor ligands. | 2010-12-05 |
|
| Pterostilbene inhibits colorectal aberrant crypt foci (ACF) and colon carcinogenesis via suppression of multiple signal transduction pathways in azoxymethane-treated mice. | 2010-08-11 |
|
| In vitro evaluation of the cytotoxic, anti-proliferative and anti-oxidant properties of pterostilbene isolated from Pterocarpus marsupium. | 2010-06 |
|
| Pterostilbene, a natural dimethylated analog of resveratrol, inhibits rat aortic vascular smooth muscle cell proliferation by blocking Akt-dependent pathway. | 2009-10-06 |
|
| Anti-inflammatory action of pterostilbene is mediated through the p38 mitogen-activated protein kinase pathway in colon cancer cells. | 2009-07 |
|
| Pterostilbene inhibited tumor invasion via suppressing multiple signal transduction pathways in human hepatocellular carcinoma cells. | 2009-07 |
|
| Natural polyphenols facilitate elimination of HT-29 colorectal cancer xenografts by chemoradiotherapy: a Bcl-2- and superoxide dismutase 2-dependent mechanism. | 2008-10 |
|
| Pterostilbene is equally potent as resveratrol in inhibiting 12-O-tetradecanoylphorbol-13-acetate activated NFkappaB, AP-1, COX-2, and iNOS in mouse epidermis. | 2008-06 |
|
| Nitric oxide mediates natural polyphenol-induced Bcl-2 down-regulation and activation of cell death in metastatic B16 melanoma. | 2007-02-02 |
|
| Effect of natural analogues of trans-resveratrol on cytochromes P4501A2 and 2E1 catalytic activities. | 2006-04 |
|
| Pterostilbene, a new agonist for the peroxisome proliferator-activated receptor alpha-isoform, lowers plasma lipoproteins and cholesterol in hypercholesterolemic hamsters. | 2005-05-04 |
Sample Use Guides
In Vivo Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/25057276
50 mg or 125 mg twice daily for 6-8 weeks
Route of Administration:
Oral
In Vitro Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/11316812
Pterostilbene inhibited the growth of normal fibroblasts in a dose-dependent manner similar to resveratrol (IC50 60 uM for both), and pterostilbene also caused cell cycle imbalance in a manner similar to that of resveratrol.
| Substance Class |
Chemical
Created
by
admin
on
Edited
Mon Mar 31 22:01:08 GMT 2025
by
admin
on
Mon Mar 31 22:01:08 GMT 2025
|
| Record UNII |
26R60S6A5I
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Preferred Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
DSLD |
1717 (Number of products:177)
Created by
admin on Mon Mar 31 22:01:08 GMT 2025 , Edited by admin on Mon Mar 31 22:01:08 GMT 2025
|
||
|
FDA ORPHAN DRUG |
628218
Created by
admin on Mon Mar 31 22:01:08 GMT 2025 , Edited by admin on Mon Mar 31 22:01:08 GMT 2025
|
||
|
NCI_THESAURUS |
C275
Created by
admin on Mon Mar 31 22:01:08 GMT 2025 , Edited by admin on Mon Mar 31 22:01:08 GMT 2025
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
100000176848
Created by
admin on Mon Mar 31 22:01:08 GMT 2025 , Edited by admin on Mon Mar 31 22:01:08 GMT 2025
|
PRIMARY | |||
|
26R60S6A5I
Created by
admin on Mon Mar 31 22:01:08 GMT 2025 , Edited by admin on Mon Mar 31 22:01:08 GMT 2025
|
PRIMARY | |||
|
Pterostilbene
Created by
admin on Mon Mar 31 22:01:08 GMT 2025 , Edited by admin on Mon Mar 31 22:01:08 GMT 2025
|
PRIMARY | |||
|
18259-15-9
Created by
admin on Mon Mar 31 22:01:08 GMT 2025 , Edited by admin on Mon Mar 31 22:01:08 GMT 2025
|
NON-SPECIFIC STEREOCHEMISTRY | |||
|
8630
Created by
admin on Mon Mar 31 22:01:08 GMT 2025 , Edited by admin on Mon Mar 31 22:01:08 GMT 2025
|
PRIMARY | |||
|
DTXSID9041106
Created by
admin on Mon Mar 31 22:01:08 GMT 2025 , Edited by admin on Mon Mar 31 22:01:08 GMT 2025
|
PRIMARY | |||
|
537-42-8
Created by
admin on Mon Mar 31 22:01:08 GMT 2025 , Edited by admin on Mon Mar 31 22:01:08 GMT 2025
|
PRIMARY | |||
|
C153353
Created by
admin on Mon Mar 31 22:01:08 GMT 2025 , Edited by admin on Mon Mar 31 22:01:08 GMT 2025
|
PRIMARY | |||
|
5281727
Created by
admin on Mon Mar 31 22:01:08 GMT 2025 , Edited by admin on Mon Mar 31 22:01:08 GMT 2025
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
PARENT -> ACTIVE CONSTITUENT ALWAYS PRESENT | |||
|
|
PARENT -> CONSTITUENT ALWAYS PRESENT |